8-KOther Events

VERTEX PHARMACEUTICALS INC / MA 8-K Report (Apr 24, 2003)

Filed April 24, 2003For Securities:VRTX

Summary

Vertex Pharmaceuticals Incorporated (VRTX) filed an 8-K report on April 24, 2003, to disclose its financial results for the quarter ended March 31, 2003. This filing primarily serves as a means to disseminate this important financial information to the public under Regulation FD, ensuring all investors have access to the same material updates simultaneously. Investors should note that this report is distinct from detailed financial statements typically found in a 10-Q filing. Its core purpose is to provide timely notification of the company's performance. While the full press release detailing the results is attached as an exhibit, the 8-K itself functions as the official notification mechanism for these financial outcomes.

Key Highlights

  • 1Vertex Pharmaceuticals Inc. filed an 8-K report on April 24, 2003.
  • 2The report's primary purpose is to disclose financial results for the quarter ended March 31, 2003.
  • 3The information is furnished under Item 9 (Regulation FD Disclosure) to ensure fair and timely dissemination of material non-public information.
  • 4A press release detailing the financial results for the quarter is attached as Exhibit 99.1.
  • 5This filing does not constitute a formal filing for Section 18 of the Exchange Act or incorporation by reference into other filings, but rather a method of public disclosure.
  • 6The company is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose Vertex Pharmaceuticals' financial results for the quarter ended March 31, 2003, in compliance with Regulation FD, ensuring that all investors receive this information simultaneously.

The detailed financial results are provided in the press release attached to this 8-K filing as Exhibit 99.1. Investors should refer to that exhibit for specific financial performance data.

This 8-K filing serves as a disclosure of financial results via a press release. It does not contain full audited financial statements; those would typically be found in a Form 10-Q (quarterly) or 10-K (annual) filing.

According to the filing, the information is furnished under Item 9 (Regulation FD Disclosure) and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor is it automatically incorporated by reference into other filings.